Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Link
http://link.springer.com/content/pdf/10.1007/s40266-019-00696-3.pdf
Reference96 articles.
1. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification for renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69:1945–53.
2. Danese MD, Kim J, Doan QV, et al. PTH and the risk for hip, vertebral and pelvic fractures among patients on dialysis. Am J Kidnei Dis. 2006;47(1):149–56.
3. Fernandez-Martìn JL, Carrero JJ, Benedik M, et al. COSMOS: the dialysis scenario of CKD–MBD in Europe. Nephrol Dial Transplant. 2013;28(7):1922–35.
4. Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10:98–109.
5. Fouque D, Roth H, Pelletier S, et al. Control of mineral metabolism and bone disease in haemodialsysis patients: which optimal targets? Nephrol Dial Transplant. 2011;26:1948–55.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intradialytic serum phosphate variations are associated with low PTH levels;Journal of Nephrology;2024-08-23
2. Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3–5 not receiving dialysis;Frontiers in Endocrinology;2024-07-04
3. Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs;Expert Opinion on Investigational Drugs;2024-06-19
4. Efficacy of Radiofrequency Ablation/Microwave Ablation Technology for Treatment of Chronic Kidney Disease Complicated with Secondary Hyperparathyroidism;Journal of Biomedical Nanotechnology;2023-08-01
5. The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?;Clinical Kidney Journal;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3